✦ LIBER ✦

6511 ORAL Phase II study of erlotinib (E) with or without sunitinib (SU) in the treatment of metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Blumenschein, G.R.; Robert, F.; Melnyk, O.; Sutherland, K.C.; Tye, L.; Wang, E.; Chao, R.; Fossella, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6548 POSTER Phase II study of sunitinib

✍ Gervais, R.; Hainsworth, J.D.; Blais, N.; Soria, J.C.; Laskin, J.; Hamm, J.T.; L 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II study of sunitinib as maintenan

✍ Gervais, Radj; Hainsworth, John D.; Blais, Normand; Besse, Benjamin; Laskin, Jan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

9174 Phase II study of everolimus plus e

✍ Soria, J.C.; Bennouna, J.; Leighl, N.; Khuri, F.; Traynor, A.M.; Johnson, B.; Ka 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Phase II Study of Continuous Daily Sunit

✍ G.V. Scagliotti; H.H. Gillenwater; J.R. Brahmer; R. Govindan; R. Rosell; C.P. Be 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Phase II study of paclitaxel and oral et

✍ Boyer, Michael J; Mitchell, Paul; Goldstein, David; Millward, Michael J; Olver, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 71 KB

6513 ORAL A phase II study of erlotinib

✍ Dingemans, A.; Groen, H.J.M.; Smit, E.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB